Laser Speckle Imaging for Wound Perfusion Monitoring (WoundImager)

CW Optics, Inc.1 site in 1 country20 target enrollmentAugust 2012

ConditionsWounds and Injuries

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Wounds and Injuries
Sponsor: CW Optics, Inc.
Enrollment: 20
Locations: 1
Primary Endpoint: Blood flow velocity measurements
Status: Completed
Last Updated: 12 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to investigate the efficacy of an optical device designed and developed to quantitatively monitor blood flow velocity of wound sites. It is hypothesized that the blood flow velocity of the wound site will provide critical information on the efficacy of hyperbaric oxygen therapy.

Registry

clinicaltrials.gov

Start Date

August 2012

End Date

April 2013

Last Updated

12 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

CW Optics, Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Blood flow velocity measurements

Time Frame: 5 months

Effectiveness of blood flow velocity measurements of wound sites to assess tissue viability with a novel optical device. Comparison between the responses of patients treated with hyperbaric oxygen therapy and those treated by other means will be made.